New horizons in target antigen selection in adoptive cell therapy of cancer

Q Medicine

癌症 Pub Date : 2015-04-01 DOI:10.3872/J.ISSN.1007-385X.2015.02.009

W. Feng, R. Xiu-bao

引用次数: 0

查看原文本刊更多论文

肿瘤过继细胞治疗中靶抗原选择的新进展

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

癌症 ONCOLOGY-

CiteScore

3.47

自引率

0.00%

发文量

9010

审稿时长

12 weeks

期刊介绍： In July 2008, Landes Bioscience and Sun Yat-sen University Cancer Center began co-publishing the international, English-language version of AI ZHENG or the Chinese Journal of Cancer (CJC). CJC publishes original research, reviews, extra views, perspectives, supplements, and spotlights in all areas of cancer research. The primary criteria for publication in CJC are originality, outstanding scientific merit, and general interest. The Editorial Board is composed of members from around the world, who will strive to maintain the highest standards for excellence in order to generate a valuable resource for an international readership.